All builds

Liquid Handling · Bioprinting · Extrusion · 2019 · HardwareX

Nydus One Syringe Extruder (NOSE): A Prusa i3 3D printer conversion for bioprinting applications

Bioprinting, combined with other tissue engineering techniques, is a promising method to create engineered tissues or standardized 3D cell culturing models. It has potential applications in the development of animal free models for drug toxicity screenings or for personalized medicine approaches.

Performance the paper reports

0 of 5
  1. Motion—Motion accuracy: not reported
  2. Volume—Volumetric accuracy: not reported
  3. Viability—Cell viability: not reported
  4. Unattended—Unattended operation: not reported
  5. Standard—Standard compliance: not reported

The full text was read and states no figure for any of the five.

How hard this is to adopt

3.1 of 5, higher is easier

Each score is shown against the range the other 59 builds actually occupy, because no criterion uses the full 1–5 scale. These describe how reproducible the build is, not how good the science is.

  • Resolution

    2/1–5

    Smallest feature/positioning evidence about 500 µm.

  • Throughput

    2/2–5

    Operation appears single-unit or manually constrained.

  • Parts sourcing

    3/2–4

    Mix of common parts and custom/printed components.

  • Skill needed

    3/2–4

    Multiple technical skills appear required.

  • Facilities needed

    3/2–4

    Requires accessible but nontrivial lab/maker equipment.

  • Documentation

    4/2–5

    Open resources include several build or operation artifacts.

  • Validation effort

    4/2–4

    Validation includes standards, benchmarking, replicates, or multi-condition tests.

  • Cycle time

    4/1–4

    Speed evidence suggests rapid, real-time, or automated operation.

2 further criteria are recorded but not shown
  • Application Level — scored 4 (75% of records share one value), so it cannot separate one build from another.
  • Build Time (scored for only 6 of 60 records), so it cannot separate one build from another.

Both remain in the published dataset.

Have you built this?

Report what it took, including attempts that stalled. A failed build tells the next laboratory what the documentation leaves out.

Report a rebuild

Know what this record is missing?

The index has no which files exist (CAD, bill of materials, firmware…) for this build. If you are an author or have built it, you know; a GitHub issue pre-filled with this record takes a minute.

Fill the gap
Record metadata
Publication data

Matched by doi · retrieved 2026-07-21

Abstract

Bioprinting, combined with other tissue engineering techniques, is a promising method to create engineered tissues or standardized 3D cell culturing models. It has potential applications in the development of animal free models for drug toxicity screenings or for personalized medicine approaches. Here we report the conversion of the worldwide used open source 3D printer (RepRap, Prusa i3) to a functional and affordable bioprinter by substituting the common plastic-extruder with the Nydus One Syringe Extruder (NOSE). The NOSE modification enables mechanical hydrogel extrusion as well as a tunable deposition precision and volume by featuring a modular syringe-holder concept. A cost effective and simple hardware design including a custom software (termed ‘composer’) was developed to prove that this technique can be made accessible for a broader public. Furthermore, the printing procedure was optimized for the peer-reviewed FRESH-method by Hinton et al. which allows to print geometrical complex cell-laden constructs. We provide a detailed protocol on the creation of the FRESH-gel to ensure the reproducibility of this state of the art method. As a proof of concept HEK293 cells as well as mouse embryonic stem cells (mESC) were utilized for cell-laden printing. Depending on the cellular source the survival rates range from 60% up to 95%. Automatized quantitative viability analysis was performed using the open source image analysis tool Icy, in particular the “spot detector” plugin. A detailed protocol allows the recreation of the assay. Further data utilizing a support bath printing technique reveal limitations regarding the printing and residential time of cell-laden constructs. Keywords: Open Source Bioprinter, RepRap Modificiation, Mechanical Syringe Extruder, Bioprinting Protocol, Bioprinting Software

Bibliographic details

Published
2019-06-11
Journal/source
HardwareX
Publisher
Elsevier BV
DOI
10.1016/j.ohx.2019.e00069
Type
journal-article
Language
en
Volume / issue
6
Pages
e00069
ISSN
2468-0672

Access and metrics

Open access
Yes
OA status
gold
License
cc-by
Version
publishedVersion
Cited by
67
References
19
Retracted
No

Authors and affiliations

  1. Nils BesslerCorresponding authorRuhr University Bochum
  2. Dennis OgiermannRuhr University Bochum
  3. Maj‐Britt BuchholzUniversity Medical Center Utrecht
  4. Alexander SantelRuhr University Bochum
  5. J. HeidenreichRuhr University Bochum
  6. Rawas AhmmedRuhr University Bochum
  7. Holm ZaehresRuhr University Bochum
  8. Beate Brand-SaberiCorresponding authorRuhr University Bochum

Topics and keywords

3D Printing in Biomedical ResearchAdditive Manufacturing and 3D Printing TechnologiesPluripotent Stem Cells ResearchModular designSyringeComputer scienceProtocol (science)3D printing3d printerBiomedical engineeringEmbedded systemComputer hardwareNanotechnologyMaterials scienceEngineering

Funding

  • Ruhr-Universität Bochum
Perspective and practical signals

Why it matters

Often referenced for syringe-based extrusion designs; adjacent to extrusion bioprinting toolchains.

Limitations

No limitation note curated yet.